US 2021/0275577 A1Published application

Molecular hydrogen-containing composition for regulating intracellular signal transduction

AssigneesMiz Co., Ltd., Osaka University

InventorsFumitake SATOH, Bunpei SATO, Shinichi HIRANO, Ryosuke KUROKAWA, Yusuke ICHIKAWA, Hiroshi MATSUURA, Kentaro SHIMIZU, Hiroshi OGURA, Takeshi SHIMAZU

Life of this patent

Estimating the term…

patentgrep

Loading patent…

Abstract

The present invention provides a composition for regulating intracellular signal transduction. More specifically, the present invention provides a composition for prevention and/or improvement of a symptom associated with intracellular signal transduction in a subject, comprising molecular hydrogen as an active ingredient.

Claims20

Dependent claims

A method for regulating intracellular signal transduction, comprising administering a composition containing an effective amount of molecular hydrogen.

Dependencies are inferred from the claim text.

Facts

Application: 17/191,417Filed 3 Mar 2021
Priority: JP 2020-0568389 Mar 2020
Published: 9 Sep 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 33/00
Medicinal preparations containing inorganic active ingredients
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/007
Galenical forms characterised by the site of application: pulmonary tract; Aromatherapy

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key